Company Filing History:
Years Active: 1984
Title: Rosette Lidereau: Innovator in Leukemia Treatment
Introduction
Rosette Lidereau is a notable inventor based in Colombes, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds useful for the treatment of leukemias. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Lidereau holds a patent for Pyrido (4,3-B) carbazoles substituted in the 1 position by a polyamine. This novel derivative corresponds to a specific general formula, where R₁ is a Y–(CH₂)ₙ–NR₄R₅ group. In this formula, Y can represent a single bond or a specific group, while R₄ and R₅ can be hydrogen or an alkyl radical. The patent highlights the potential of these compounds in treating leukemia, showcasing Lidereau's commitment to addressing critical health challenges.
Career Highlights
Rosette Lidereau has been associated with the Agence Nationale De Valorisation De La Recherche, where she has contributed her expertise in research and development. Her work has been instrumental in advancing the understanding of chemical compounds that can be utilized in medical treatments. Lidereau's innovative spirit and dedication to her field have earned her recognition among her peers.
Collaborations
Throughout her career, Lidereau has collaborated with esteemed colleagues, including Emile R. Bisagni and Claire Ducrocq. These collaborations have fostered a productive environment for research and innovation, allowing for the exchange of ideas and expertise in the field of medicinal chemistry.
Conclusion
Rosette Lidereau's contributions to the field of leukemia treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire future research and development in the area of medicinal chemistry.